Ads
related to: meniere's syndrome vertigo
Search results
Results From The WOW.Com Content Network
Ménière's disease is characterized by episodes of vertigo, worsening hearing loss, and tinnitus. A comprehensive hearing and vestibular evaluation is essential for proper diagnosis of Ménière's.
To assist with vertigo and balance problems, glycopyrrolate has been found to be a useful vestibular suppressant in patients with Ménière's disease. [ 21 ] Diuretics , such as the thiazide-like diuretic chlortalidone , are widely used to manage MD on the theory that it reduces fluid buildup (pressure) in the ear. [ 22 ]
Dizziness affects approximately 20–40% of people at some point in time, while about 7.5–10% have vertigo. [3] About 5% have vertigo in a given year. [10] It becomes more common with age and affects women two to three times more often than men. [10] Vertigo accounts for about 2–3% of emergency department visits in the developed world. [10]
The study found that the majority of patients with Meniere's disease (104 out of 163, or 63.80%) presented vertigo with their first symptoms, and only 59 out of 163 (36.19%) of patients presented with cochlear symptoms first, such as "tinnitus or deafness."
Each episode of vertigo typically lasts less than one minute. [3] Nausea is commonly associated. [7] BPPV is one of the most common causes of vertigo. [1] [2] [8] BPPV is a type of balance disorder along with labyrinthitis and Ménière's disease. [3] It can result from a head injury or simply occur among those who are older. [3]
Cinnarizine is predominantly used to treat nausea and vomiting associated with motion sickness, [6] vertigo, [8] Ménière's disease, [9] or Cogan's syndrome. [3] It is one of only a few drugs that has a beneficial effect in the chronic treatment of the vertigo and tinnitus associated with Ménière's disease.
Betahistine, sold under the brand name Serc among others, is an anti-vertigo medication.It is commonly prescribed for balance disorders or to alleviate vertigo symptoms.It was first registered in Europe in 1970 for the treatment of Ménière's disease, but current evidence does not support its efficacy in treating it.
Prosper Menière (18 June 1799 – 7 February 1862) was a French medical doctor who first identified that the inner ear could be the source of a condition combining vertigo, hearing loss and tinnitus, [1] which is now known as Ménière's disease.